Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Varex Imaging (VREX) Free Cash Flow (2016 - 2026)

Varex Imaging (VREX) has disclosed Free Cash Flow for 11 consecutive years, with -$26.8 million as the latest value for Q1 2026.

  • On a quarterly basis, Free Cash Flow fell 605.66% to -$26.8 million in Q1 2026 year-over-year; TTM through Jan 2026 was -$13.3 million, a 151.55% decrease, with the full-year FY2025 number at $18.8 million, down 7.84% from a year prior.
  • Free Cash Flow was -$26.8 million for Q1 2026 at Varex Imaging, down from $2.3 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $41.7 million in Q3 2023 to a low of -$26.8 million in Q1 2026.
  • A 5-year average of $5.6 million and a median of $2.8 million in 2024 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: skyrocketed 5400.0% in 2025, then crashed 605.66% in 2026.
  • Varex Imaging's Free Cash Flow stood at -$9.2 million in 2022, then skyrocketed by 98.91% to -$100000.0 in 2023, then skyrocketed by 20000.0% to $19.9 million in 2024, then crashed by 88.44% to $2.3 million in 2025, then crashed by 1265.22% to -$26.8 million in 2026.
  • Per Business Quant, the three most recent readings for VREX's Free Cash Flow are -$26.8 million (Q1 2026), $2.3 million (Q4 2025), and $1.4 million (Q3 2025).